Security key
26253C102
- Security type / class
- Equity / COM
- Total 13F shares
- 3,738,009
- Total 13F value
- $449,307
- Share change
- +330,263
- SEC-reported price per share
- $0.12
- Number of holders
- 20
- Value change
- +$39,421
- Number of buys
- 12
- Number of sells
- 5
Report period
Q4 2023
Institutions
20
Top holders
10
DSS full security history
Ownership snapshot
Full 13F holder table
DSS, INC. SEC filings
DSS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of DSS - DSS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Global BioMedical Pte. Ltd.
Disclosed value leader
Global BioMedical Pte. Ltd.
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5
13F
Highest disclosed value: $1,012,980
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Global BioMedical Pte. Ltd. has the largest disclosed position value at $1.01M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Global BioMedical Pte. Ltd.'s linked filing trail.
Disclosed position value
Top 5
Global BioMedical Pte. Ltd.
$1.01M
VANGUARD GROUP INC
$323.2K
Frank D. Heuszel
$172K
GEODE CAPITAL MANAGEMENT, LLC
$91.1K
BlackRock Finance, Inc.
$77.6K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Global BioMedical Pte. Ltd. |
3/4/5
Former 10% Owner
|
—
denominator unverified
|
$1,012,980
7,732,671 shares
|
— | 08 Sep 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$323,177
1,757,353 shares
|
— | 30 Sep 2023 |
| Frank D. Heuszel |
3/4/5
Chief Executive Officer, Director
|
—
denominator unverified
|
$171,974
1,312,776 shares
|
— | 10 Apr 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$91,128
495,351 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$77,569
421,797 shares
|
— | 30 Sep 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$70,000
378,469 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
20
Shares
3,738,009
Rows available
20
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
19
Q4 2023 holders
20
Holder diff
1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|